BioWorld MedTech

Dec. 9, 2013

Boston Sci has favorable results for Precision Spectra SCS study

A study evaluating Boston Scientific's (Natick, Massachusetts) Precision Spectra Spinal Cord Stimulator (SCS), shows that the device provides highly significant pain relief three months after implantation. Read More

Life science VC funding seen falling behind overall funding growth rates

BSD begins selling MicroThermX microwave ablation in Turkey

Financings roundup: Physicians Trust prices 8.3M shares, seeks to raise more than $89 million

Grants roundup: QED program grants $600,000 to support four new technologies

Agreements/contracts: Boston Sci, Medicines Co. co-promote Premier stent

Med-tech Notes

Product briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 29, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 29, 2026.

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

Brain-derived tau in blood predicts stroke severity and outcome

BioWorld Science

Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

Centessa’s CNT-9982 shows promise for MDD

BioWorld Science

Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...